Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Research and development

Research and development - MRTP

Sales, general and administrative

Impairment of intangible assets

Depreciation

Amortization

Other operating expense, net

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

22nd Century Group

22nd Century Group, Inc. is a biotechnology company, which develops disruptive plant-based solutions the for life science, consumer product, and pharmaceutical markets. It focuses on technologies that alter the level of nicotine in tobacco plants and the level of cannabinoids in hemp or cannabis plants through genetic engineering, gene-editing, and modern plant breeding techniques. The company was founded on September 12, 2005 and is headquartered in Buffalo, NY.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

22nd Century Group advances VLN and GVB units towards profitability

22nd Century Group's Q4 2022 earnings call highlighted progress in VLN tobacco and GVB hemp/cannabis units, with plans for multi-state launches and cash positive operations in 2024. Despite challenges like the Grass Valley facility fire, the company remains focused on achieving profitability through revenue growth and market expansion. Key strengths include successful pilot results, volume growth, and a clear path to cash positivity for both business units.

22nd Century Group (XXII) reports strong Q1 performance and growth strategies

22nd Century Group (XXII) showcases strong performance and strategic initiatives to drive revenue growth and achieve cash positivity by 2024.
Despite challenges such as analyst inquiries and insurance impacts, the company's focus on cost efficiencies and margin improvements positions it for success.
Opportunities in revenue growth, bulk ingredient capacity expansion, and margin enhancements present promising prospects for future profitability and market growth.

22nd Century Group reports strong Q2 performance amidst operational challenges

22nd Century Group's Q2 performance showcased growth in sales but faced challenges in gross profit due to production mix shifts.
The company's proactive strategies for cost savings, brand value creation, and gross margin improvement indicate a focus on long-term sustainability.
Despite challenges like VLN rollout delays and tobacco business hurdles, opportunities in market differentiation and efficiency improvements are being pursued.

22nd Century Group pursues profitability through strategic shifts and cost management

22nd Century Group's Q4 2023 earnings call highlighted efforts to achieve profitability by reducing cash burn, focusing on VLN cigarettes for harm reduction, and exploring CMO opportunities in tobacco manufacturing. Despite challenges like decreased net sales and a negative gross profit, the company aims to reach breakeven by Q1 2025.

22nd Century Group reduces cash burn, aims for profitability by 2025

22nd Century Group's Q1 2024 performance reflects progress towards profitability, with improved financial discipline and operational efficiency.
While facing revenue challenges and legal disputes, the company's strategic initiatives and investor support position it for future growth and success.
The focus on reducing losses, strengthening the balance sheet, and expanding market presence underscores the company's commitment to long-term sustainability.

22nd Century Group reports Q2 financial turnaround and growth strategies

22nd Century Group's Q2 2024 performance reflects a notable financial turnaround and progress towards profitability.
Strategic initiatives, leadership appointments, and product strategies position the company for future growth and success.
While challenges remain in achieving cash positive operations, opportunities in market expansion and product innovation offer avenues for continued advancement.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

22nd Century Group, Inc. is a biotechnology company, which engages in the business of tobacco harm reduction, reduced nicotine tobacco, and improvement of health and wellness through plant science. It operates through the Tobacco and Hemp/Cannabis segments. The Tobacco segment manufactures branded filtered cigars and cigarettes. The Hemp/Cannabis segment focuses on the bulk ingredient distillate or isolate. The company was founded on September 12, 2005 and is headquartered in Buffalo, NY.

New Contracts to Boost Second Quarter Revenue Reduced Operating Costs, Improved Cash Position Reduced ~$8.0 Million of Outstanding Debt and Liabilities for Equity Exchanges in Q2 2024 Mocksville, North Carolina--(Newsfile Corp. - May 15, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction, today reported results for the first quarter ended March 31, 2024, and provided an update on recent business highlights. First Quarter 2024 Financial Results All figures reported below reflect continuing operations, excluding discontinued operations related to the sale and exit of its hemp/cannabis franchise in late 2023.

22nd Century Group Reports First Quarter 2024 Financial Results

Continues to Improve Balance Sheet and Move Toward Cash Positive Operations Mocksville, North Carolina--(Newsfile Corp. - May 13, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction, today announced that it has entered into a binding letter of agreement to eliminate an additional $2.3 million in outstanding debt with JGB Capital. Under the terms of the agreement, the Company and JGB Capital will exchange an aggregate of $2.3M in principal, fees and expenses owed to JGB Capital for consideration of approximately 1.375 million shares of the Company's common stock and pre-funded warrants.

22nd Century Eliminates an Additional $2.3 Million of Debt

Mocksville, North Carolina--(Newsfile Corp. - May 8, 2024) - 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company focused on nicotine harm reduction, today announced that it will present at the Aegis Capital Virtual Conference on Thursday, May 9, 2024 at 2:30 PM Eastern Time. To access the live presentation, please use the events link online at https://ir.xxiicentury.com/.

22nd Century Group to Participate in the Aegis Capital Virtual Conference on May 9, 2024

Mocksville, North Carolina--(Newsfile Corp. - May 7, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco company focused on tobacco harm reduction to improve health and wellness, will host a live webcast on Wednesday, May 15, 2024, at 8:00 AM ET to discuss its 2024 first quarter results, which are to be reported in a press release at 6:00 AM ET the same day. During the webcast, Larry Firestone, chairman and chief executive officer, and Dan Otto, chief financial officer, will review financial results and discuss progress made in the recent months.

22nd Century Group (XXII) to Announce First Quarter 2024 Results on May 15, 2024

Improves Balance Sheet, Eliminates Future Omnia Interest Expense and Increases Shareholder Equity Mocksville, North Carolina--(Newsfile Corp. - April 30, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction, today announced that it has entered into a binding letter of agreement to redeem $5.2 million in outstanding principal and interest associated with the Omnia subordinated note and outstanding warrants. The agreement will exchange consideration of approximately $248,000 in cash, 1.15 million shares of common stock priced at $2.14 per share, and 1.15 million shares of pre-funded warrants priced at $2.14 per share as consideration of the debt.

22nd Century Eliminates $5.2 Million of Debt in Above-Market Equity Transaction

Intends to Reduce Board to Four Seats in Upcoming Proxy Mocksville, North Carolina--(Newsfile Corp. - April 18, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction, today announced that Nora Sullivan and James Mish have resigned as a Directors, effective immediately. The Company does not intend to fill the vacated seats and will instead reduce the board to 4 seats as part of its focus on corporate cost efficiency.

22nd Century Group Announces Resignation of Sullivan and Mish from the Board of Directors

Continues Focus on Growing Sales with New Contracts, Progress Toward Cash Positive Operations Mocksville, North Carolina--(Newsfile Corp. - April 18, 2024) - 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company focused on nicotine harm reduction, today announced that it has received notice from The Nasdaq Stock Market LLC ("Nasdaq") that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) (the "Rule") for continued listing. Said Larry Firestone, Chairman and CEO: "We are pleased to regain compliance with the Nasdaq listing standards related to minimum bid price, another win in our efforts to improve our business step by step, every day, with steady progress on all fronts.

22nd Century Group Regains Compliance with NASDAQ Minimum Bid Price Rule

Mocksville, North Carolina--(Newsfile Corp. - April 15, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction, today announced that it will present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 at 3:30 PM Pacific Time. To access the live presentation, please use the following information:Date: Wednesday, May 1, 2024Time: 3:30 PM Pacific TimeWebcast: https://ir.xxiicentury.com/ Management will also host individual investor meetings on Thursday, May 2, 2024, as part of its participation in the conference.

22nd Century Group to Participate in the Planet MicroCap Showcase on May 1-2, 2024

Pinnacle Branded Products Growing At Over 10% at Top-5 U.S. C-Store Chain Mocksville, North Carolina--(Newsfile Corp. - April 11, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction, today announced that it has expanded its Pinnacle private label brand to add distribution of cigarillo products to its existing Pinnacle cigarette products. Pinnacle products are currently sold as a private label brand in a top-5 U.S. gas station convenience store chain comprising approximately 1,700 stores in 26 states.

22nd Century Group Expands CMO Business with New Pinnacle Brand Cigarillo Products

Company Bolsters Balance Sheet with $4.2 Million Capital Infusion New Senior Leadership Team Announced to Further Drive Shareholder Value Mocksville, North Carolina--(Newsfile Corp. - April 8, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction, today announced that it has entered into a binding letter of agreement with its senior secured lender, intended to eliminate all of its senior secured debt through potential debt for equity exchanges. Additionally, the Company has entered into separate definitive agreements for the purchase of common stock and warrants.

22nd Century Announces Plan to Eliminate Its Senior Secured Debt

22nd Century (NASDAQ: XXII ) stock is falling on Monday as the tobacco products company is in danger of being delisted from the Nasdaq Exchange . The tobacco company was sent a delisting notice from the Nasdaq Listing Qualifications Department last week.

Why Is 22nd Century (XXII) Stock Down 33% Today?

Shares of tobacco specialist 22nd Century Group (NASDAQ: XXII ) are up today after the company announced a “significant” new contract manufacturing agreement. The deal centers on the production of branded conventional cigarette products.

Why Is 22nd Century Group (XXII) Stock Up 100% Today?

New Contract Will Commence in Second Quarter, Ultimately Boost CMO Volumes by More Than 20% Mocksville, North Carolina--(Newsfile Corp. - April 4, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction, today announced that it has signed a significant new contract manufacturing agreement for the production of branded conventional cigarette products. The contract, which will commence revenue generation in the second quarter of 2024, is expected to increase carton production volumes at 22nd Century's manufacturing facility by more than 20 percent when fully implemented.

22nd Century Group (XXII) Signs Large New CMO Customer

22nd Century Group, Inc. (XXII) Q4 2023 Earnings Call Transcript

Mocksville, North Carolina--(Newsfile Corp. - March 28, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction, today reported results for the fourth quarter ended December 31, 2023, and provided an update on recent business highlights. Fourth quarter results and recent business activities included: Net revenue from continuing operations in the fourth quarter of 2023 was $7.4 million, Exited hemp/cannabis operations to fully focus on tobacco harm reduction and contract manufacturing activities, Substantially reduced operating costs through efficiency initiatives and the hemp/cannabis business sale, Began new initiatives to increase sales, improve gross margin and increase operating profit in 2024, and Commenced developing new customer engagement strategies to drive additional sales growth in the FDA authorized VLN® products available in more than 5,100 stores across 26 states.

22nd Century Group (XXII) Reports Fourth Quarter 2023 Financial Results

Mocksville, North Carolina--(Newsfile Corp. - March 15, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco company focused on tobacco harm reduction to improve smoker health and wellness, will host a live webcast on Thursday, March 28, 2024, at 8:00 AM ET to discuss its 2023 fourth quarter results, which are to be reported in a press release at 6:00 AM ET the same day. During the webcast, Larry Firestone, chairman and chief executive officer, and Hugh Kinsman, chief financial officer, will review financial results and discuss progress made in the recent months.

22nd Century Group to Announce Fourth Quarter 2023 Results on March 28, 2024

Altria

Philip Morris

The Zacks Tobacco industry companies have been benefiting from their pricing power and strength in smoke-free products amid an inflationary landscape. These upsides keep Philip Morris (PM), Altria Group (MO) and 22nd Century Group (XXII) well-placed.

3 Tobacco Stocks Grabbing Attention on Solid Industry Trends

Reduced Cost Structure Expected to Save more than $1Million Annually in 2024, Aligns Board with Corporate-Wide Lean Operating Commitment Mocksville, North Carolina--(Newsfile Corp. - February 13, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII) (the "Company" or "22nd Century"), a biotechnology company focused on utilizing advanced plant technologies to improve health and wellness, today announced a reduction in board compensation expenses expected to save more than $1 million in annual cost for 2024. In addition to the newly reduced cash compensation structure going forward, the board has also waived any cash compensation due to non-employee directors for the fourth quarter of 2023 and the first quarter of 2024 and voted to forgo any equity compensation grants for directors in 2024.

22nd Century Group Announces Reduction in Board Compensation

Mocksville, North Carolina--(Newsfile Corp. - February 6, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII) (the "Company" or "22nd Century"), a biotechnology company focused on utilizing advanced plant technologies to improve health and wellness, today announced that the Company will present at the Emerging Growth Conference on February 8, 2024. Larry Firestone, Chairman and Chief Executive Officer, will present as part of an interactive Q&A session with the conference host at 10:50 am Eastern Time.

22nd Century Group to Present at the Emerging Growth Conference on February 8, 2024

Transforming Business into Lean Operating Base, Extending Cash Runway, Shareholder Meeting to Re-convene February 15 Mocksville, North Carolina--(Newsfile Corp. - January 24, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII) (the "Company" or "22nd Century"), a biotechnology company focused on utilizing advanced plant technologies to improve health and wellness, today announced that the Company conducted its January 24, 2024 special meeting of stockholders (the "Meeting") and adjourned the Meeting solely with respect to Proposal 2 set forth in its Definitive Proxy Statement (the "Proxy Statement") previously filed with the Securities and Exchange Commission. Proposal 2 is a proposal to increase the number of authorized number of shares of common stock.

22nd Century Group Announces Partial Adjournment of Annual Meeting for Proposal 2, All Other Proposals Passed

Fireside Chat Webcast Event to Take Place January 17, 2024 Buffalo, New York--(Newsfile Corp. - January 17, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII) (the "Company" or "22nd Century"), a biotechnology company focused on utilizing advanced plant technologies to improve health and wellness, today provided a shareholder update. "I am pleased with the progress of the company since assuming my role as Chairman and Chief Executive Officer at the start of December," stated Larry Firestone, Chairman and Chief Executive Officer of 22nd Century.

22nd Century Group Provides Shareholder Update and Highlights Insider Stock Purchases from Management

Analyst Hosted Event to Discuss Refocused Business, Cost Reductions and Turnaround Plan Buffalo, New York--(Newsfile Corp. - January 12, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII) (the "Company" or "22nd Century"), a biotechnology company focused on utilizing advanced plant technologies to improve health and wellness, today announced that it will host a fireside chat event on Wednesday, January 17, 2024 beginning at 1:00 p.m. Eastern Time.

22nd Century Group to Host Fireside Chat Event on January 17

Sale Will Significantly Reduce Operating Expenses, Ultimately Reduce Debt by $5.2 Million Buffalo, New York--(Newsfile Corp. - December 28, 2023) - 22nd Century Group, Inc. (NASDAQ: XXII) (the "Company" or "22nd Century"), a biotechnology company focused on utilizing advanced plant technologies to improve health and wellness, today announced it has closed the sale of its hemp/cannabis operations. The transaction will significantly reduce the Company's operating costs going forward, a key step in its goal to achieve cash positive operations.

22nd Century Group Completes Sale of Hemp/Cannabis Franchise

Sale and Related Actions Ultimately Expected to Reduce Debt Principal by $5.2 Million Buffalo, New York--(Newsfile Corp. - December 14, 2023) - 22nd Century Group, Inc. (NASDAQ: XXII) (the "Company" or "22nd Century"), a biotechnology company focused on utilizing advanced plant technologies to improve health and wellness, today announced it has secured the consent of its senior lender under the terms of its Senior Secured Credit Facility for the previously announced sale of its GVB Biopharma ("GVB") hemp/cannabis operations to Specialty Acquisition Corporation, a Nevada corporation (the "Buyer"), an entity affiliated with current GVB employees. The updated transaction terms include a cash payment of $1.1 million from the Buyer at closing of the sale (the "Closing") and a secured promissory note for $2.0 million issued by the Buyer to the Company's senior lender to be paid by the end of June 2024.

22nd Century Group's Senior Lender Approves Sale of Hemp/Cannabis Franchise on Improved Terms

Newly Appointed CEO Leading Restructuring to Focus on Tobacco Industry Operations, Reduce Costs Newly Appointed CEO Leading Restructuring to Focus on Tobacco Industry Operations, Reduce Costs

News for 22nd Century Group Stock (XXII)